Comparative analysis of risk factors for pathological fracture with femoral metastases - Results based on a randomised trial of radiotherapy

被引:152
作者
Van der Linden, YM
Dijkstra, PDS
Kroon, HM
Lok, JJ
Noordijk, EM
Leer, JWH
Marijnen, CAM
机构
[1] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Orthopaed Surg, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RC Leiden, Netherlands
来源
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME | 2004年 / 86B卷 / 04期
关键词
D O I
10.1302/0301-620X.86B4.14703
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
A number of risk factors based upon mostly retrospective surgical data, have been formulated in order to identify impending pathological fractures of the femur from low-risk metastases. We have followed up patients taking part in a randomised trial of radiotherapy, prospectively, in order to determine if these factors were effective in predicting fractures. In 102 patients with 110 femoral lesions, 14 fractures occurred during follow-up. The risk factors studied were increasing pain, the size of the lesion, radiographic appearance, localisation, transverse/axial/circumferential involvement of the cortex and the scoring system of Mirels. Only axial cortical involvement >30 mm (p = 0.01), and circumferential cortical involvement >50% (p = 0.03) were predictive of fracture. Mirels' scoring system was insufficiently specific to predict a fracture (p = 0.36). Our results indicate that most conventional risk factors overestimate the actual occurrence of pathological fractures of the femur. The risk factor of axial cortical involvement provides a simple, objective tool in order to decide which treatment is appropriate.
引用
收藏
页码:566 / 573
页数:8
相关论文
共 31 条
[1]   Treatment of metastatic adenocarcinoma of the pelvis and the extremities [J].
Aaron, AD .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1997, 79A (06) :917-932
[2]  
BEALS RK, 1971, CANCER, V28, P1350, DOI 10.1002/1097-0142(1971)28:5<1350::AID-CNCR2820280539>3.0.CO
[3]  
2-6
[4]  
BUNTING R, 1985, CLIN ORTHOP RELAT R, V192, P222
[5]  
Bunting RW, 2001, CANCER-AM CANCER SOC, V92, P1020, DOI 10.1002/1097-0142(20010815)92:4+<1020::AID-CNCR1415>3.0.CO
[6]  
2-I
[7]  
CHENG DS, 1980, CANCER, V45, P1533, DOI 10.1002/1097-0142(19800401)45:7<1533::AID-CNCR2820450703>3.0.CO
[8]  
2-Y
[9]   Prediction of pathological subtrochanteric fractures due to metastatic lesions [J].
Dijkstra, PDS ;
Oudkerk, M ;
Wiggers, T .
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 1997, 116 (04) :221-224
[10]  
DIJKSTRA S, 1994, EUR J SURG, V160, P535